Hidradenitis Suppurativa (HS) Case study

Click here for a PDF version of this case study

Outcomes

Innovaderm successfully managed this HS study
and this resulted in:

Enrollment completed 3 months ahead of schedule

Study Characteristics

Study Challenges and Solutions

		Challenges		Solutions
		Recruitment Several screen failures (SF) due to late availability of lab results		Pro-active monitoring of lab results regarding patients’ eligibility by project team Flagged alerts to individual sites and follow-up with central lab on unexpected delays Outcome: Screenfailure rate reduced due to early identification of lab errors and lab patients’ tests adequately screened
		Shipments Transportation fees (i.e., couriers) especially for lab samples from countries outside European Union		Thorough assessment of cost drivers for shipment frequencies (sample stability and required turn-around time to obtain results) Regrouping of shipments and modification to the lab panel to respect budgeted fees Outcome: Significant reduction in shipping costs
		Academic sites Delay in start-up activities due to large proportion of academic sites in the study		Frequent, tailored 1:1 calls with PIs prior to study initiation Site-centricity (i.e., involvement from onset of study) Outcome: Early-stage discussions with PIs helped streamlined recruitment and start-up timelines

Key Success Factors & Strategies

Optimal site selection: experienced PIs in HS and experienced Innovaderm sites

Implemented broad reach digital ad campaigns / assisted sites with the development of recruitment material

Recruitment Curve

Enrollment completed 3 months ahead of schedule

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.